Lexogen has launched TeloPrime, a full-length cDNA amplification kit that uses a technology called cap-dependent linker ligation, which has high selectivity for the 5' cap in order to amplify the intact full-length transcript. The kit is available in four, eight, and 24 prep sizes.
NuGen has launched the Ovation Fusion Panel Target Enrichment System, an assay that will detect all possible fusion events involving 446 cancer fusion genes. The assay uses NuGen's proprietary Single Primer Enrichment Technology, a single primer strategy that requires only one partner exon to be targeted, which enables detection of both known and novel fusion events, as well as alternative isoforms, according to the company. It requires 10 ng of total RNA from either fresh frozen or formalin-fixed paraffin-embedded tissue.